Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Astrazeneca (AZN) Share News

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

2nd Apr 2024 11:50

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe. Read More

AstraZeneca and Daiichi make US progress with latest licence approvals

2nd Apr 2024 10:25

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US. Read More

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

2nd Apr 2024 09:54

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning: Read More

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

2nd Apr 2024 09:09

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning. Read More

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

2nd Apr 2024 08:05

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later. Read More

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

27th Mar 2024 12:02

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday. Read More

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

27th Mar 2024 11:56

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation. Read More

AstraZeneca treatments become "first and only" to be approved in Japan

27th Mar 2024 09:19

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan. Read More

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

27th Mar 2024 09:03

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week. Read More

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

27th Mar 2024 08:02

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week. Read More

LONDON MARKET MIDDAY: Stocks make tepid start to new week

25th Mar 2024 12:09

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish. Read More

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

25th Mar 2024 09:04

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon. Read More

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

25th Mar 2024 08:40

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults. Read More

FTSE 100 Latest

Value8,809.74

Change53.53